These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33056)

  • 21. [Effect of cold adaptation of alpha- and beta-adrenergic responses of blood pressure in hindlimb and small intestine in situ and systemic blood pressure in rabbits].
    Manukhin BN; Anan'ev VN; Anan'eva OV
    Izv Akad Nauk Ser Biol; 2007; (2):171-82. PubMed ID: 17665645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of selective beta 1- and beta 2-adrenoreceptor agonists and antagonists on intraocular pressure in the cat.
    Colasanti BK; Trotter RR
    Invest Ophthalmol Vis Sci; 1981 Jan; 20(1):69-76. PubMed ID: 6108938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal cats.
    Miller PE; Rhaesa SL
    Am J Vet Res; 1996 Jan; 57(1):83-6. PubMed ID: 8720244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenergic mechanism in circadian elevation of intraocular pressure in rabbits.
    Liu JH; Dacus AC; Bartels SP
    Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2178-83. PubMed ID: 1676991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autonomic drugs in ophthalmology: some problems and promises. Section III: Sympathomimetic drugs.
    Holland MG
    Ann Ophthalmol; 1974 Sep; 6(9):875-8, 881-4, 887-8. PubMed ID: 4155259
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic and ocular effects of alpha 2-adrenergic stimulating and beta 2-blocking agents.
    Apponi-Battini G; Barra A; De Simone C; Rossi F; Berrino L; Cazzola M; Marmo E
    J Med; 1984; 15(2):126-34. PubMed ID: 6150961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of topically applied guanethidine sulphate on pupil and tension responses of the rabbit eye to (--)-adrenaline bitartrate.
    Lamble JW
    Exp Eye Res; 1974 Jul; 19(1):79-89. PubMed ID: 4416222
    [No Abstract]   [Full Text] [Related]  

  • 28. Ocular hypotensive activity of pirbuterol eye drops in rabbits.
    Bonomi L; Perfetti S; Bellucci R; De Franco I
    J Ocul Pharmacol; 1991; 7(3):191-4. PubMed ID: 1686050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of caffeine and imidazole on the actions of beta- and alpha-adrenergic stimulants, papaverine and cyclic 3', 5'-AMP.
    Takagi K; Takayanagi I; Tsuchida Y
    Jpn J Pharmacol; 1972 Jun; 22(3):403-9. PubMed ID: 4404974
    [No Abstract]   [Full Text] [Related]  

  • 30. Are beta-adrenergic mechanisms involved in ocular hypotensive actions of adrenergic drugs?
    Chiou GC; Watanabe K; McLaughlin MA; Liu HK
    Ophthalmic Res; 1985; 17(1):49-53. PubMed ID: 2858837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective suppression by bunazosin of alpha-adrenergic agonist evoked elevation of intraocular pressure in sympathectomized rabbit eyes.
    Nishimura K; Kuwayama Y; Matsugi T; Sun N; Shirasawa E
    Invest Ophthalmol Vis Sci; 1993 Apr; 34(5):1761-6. PubMed ID: 8097189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-adrenergic receptors: recognition and regulation.
    Lefkowitz RJ
    N Engl J Med; 1976 Aug; 295(6):323-8. PubMed ID: 6910
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of alpha- and beta-adrenoceptor agonists on inflammatory exudation in rabbit and guinea-pig skin [proceedings].
    Kenawy SA; Lewis GP; Williams TJ
    Br J Pharmacol; 1978 Nov; 64(3):447P-448P. PubMed ID: 31224
    [No Abstract]   [Full Text] [Related]  

  • 34. Potentiating effect of beta-adrenergic stimulant on the response of the cutaneous vascular resistance to alpha-adrenergic stimulant.
    Michibayashi T; Miyahara M
    Experientia; 1975 May; 31(5):552-4. PubMed ID: 237770
    [No Abstract]   [Full Text] [Related]  

  • 35. Adrenergic drugs and intraocular pressure: suppression of ocular hypertension induced by water loading.
    Rowland JM; Potter DE
    Exp Eye Res; 1980 Jan; 30(1):93-104. PubMed ID: 6102526
    [No Abstract]   [Full Text] [Related]  

  • 36. The adrenergic receptors of the intraocular muscles of the human eye.
    van Alphen GW
    Invest Ophthalmol; 1976 Jun; 15(6):502-5. PubMed ID: 6403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin.
    Mittag TW; Tormay A; Messenger M; Podos SM
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):163-9. PubMed ID: 2857689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular actions of moxonidine: a possible role for imidazoline receptors.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1994 Jun; 269(3):897-904. PubMed ID: 7912282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy.
    Yuen NS; Cheung P; Hui SP
    Jpn J Ophthalmol; 2005; 49(2):89-92. PubMed ID: 15838723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
    Miller PE; Nelson MJ; Rhaesa SL
    Am J Vet Res; 1996 Jan; 57(1):79-82. PubMed ID: 8720243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.